We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals.
- Authors
Williams, Joshua T. B.; Kurlandsky, Kate; Breslin, Kristin; Durfee, M. Joshua; Stein, Amy; Hurley, Laura; Shoup, Jo Ann; Reifler, Liza M.; Daley, Matthew F.; Lewin, Bruno J.; Goddard, Kristin; Henninger, Michelle L.; Nelson, Jennifer C.; Vazquez-Benitez, Gabriela; Hanson, Kayla E.; Fuller, Candace C.; Weintraub, Eric S.; McNeil, Michael M.; Hambidge, Simon J.
- Abstract
This survey study evaluates changing attitudes regarding COVID-19 vaccines by vaccination status and race, ethnicity, and language. Key Points: Question: Do perceptions of COVID-19 vaccines differ among distinct pregnant or recently pregnant respondents from 2 survey waves between November 2021 and February 2023? Findings: In this survey study, 1227 of 2956 people responded. Respondents who received 1 or more COVID-19 vaccines, identified as non-Hispanic White, and preferred the Spanish language had the largest decreases in agreement that COVID-19 vaccines are safe across waves. Meaning: These findings suggest that decreases in perceived COVID-19 vaccine safety among specific groups of insured pregnant and recently pregnant individuals is a public health concern. Importance: Pregnant people and infants are at high risk of severe COVID-19 outcomes. Understanding changes in attitudes toward COVID-19 vaccines among pregnant and recently pregnant people is important for public health messaging. Objective: To assess attitudinal trends regarding COVID-19 vaccines by (1) vaccination status and (2) race, ethnicity, and language among samples of pregnant and recently pregnant Vaccine Safety Datalink (VSD) members from 2021 to 2023. Design, Setting, and Participants: This cross-sectional surveye study included pregnant or recently pregnant members of the VSD, a collaboration of 13 health care systems and the US Centers for Disease Control and Prevention. Unvaccinated, non-Hispanic Black, and Spanish-speaking members were oversampled. Wave 1 took place from October 2021 to February 2022, and wave 2 took place from November 2022 to February 2023. Data were analyzed from May 2022 to September 2023. Exposures: Self-reported or electronic health record (EHR)–derived race, ethnicity, and preferred language. Main Outcomes and Measures: Self-reported vaccination status and attitudes toward monovalent (wave 1) or bivalent Omicron booster (wave 2) COVID-19 vaccines. Sample- and response-weighted analyses assessed attitudes by vaccination status and 3 race, ethnicity, and language groupings of interest. Results: There were 1227 respondents; all identified as female, the mean (SD) age was 31.7 (5.6) years, 356 (29.0%) identified as Black race, 555 (45.2%) identified as Hispanic ethnicity, and 445 (36.3%) preferred the Spanish language. Response rates were 43.5% for wave 1 (652 of 1500 individuals sampled) and 39.5% for wave 2 (575 of 1456 individuals sampled). Respondents were more likely than nonrespondents to be White, non-Hispanic, and vaccinated per EHR. Overall, 76.8% (95% CI, 71.5%-82.2%) reported 1 or more COVID-19 vaccinations; Spanish-speaking Hispanic respondents had the highest weighted proportion of respondents with 1 or more vaccination. Weighted estimates of somewhat or strongly agreeing that COVID-19 vaccines are safe decreased from wave 1 to 2 for respondents who reported 1 or more vaccinations (76% vs 50%; χ21 = 7.8; P <.001), non-Hispanic White respondents (72% vs 43%; χ21 = 5.4; P =.02), and Spanish-speaking Hispanic respondents (76% vs 53%; χ21 = 22.8; P =.002). Conclusions and Relevance: Decreasing confidence in COVID-19 vaccine safety in a large, diverse pregnant and recently pregnant insured population is a public health concern.
- Subjects
LANGUAGE &; languages; IMMUNIZATION; SELF-evaluation; CROSS-sectional method; PEARSON correlation (Statistics); PATIENT safety; INTERPROFESSIONAL relations; RESEARCH funding; VACCINATION; PROBABILITY theory; COVID-19 vaccines; PREGNANT women; DESCRIPTIVE statistics; CHI-squared test; ATTITUDE (Psychology); RACE; SURVEYS; ELECTRONIC health records; CENTERS for Disease Control &; Prevention (U.S.); DATA analysis software; VACCINATION status; COVID-19
- Publication
JAMA Network Open, 2024, Vol 7, Issue 4, pe245479
- ISSN
2574-3805
- Publication type
Article
- DOI
10.1001/jamanetworkopen.2024.5479